Risk factors for deep candida infections in liver transplant recipients

Transplant Proc. 1990 Aug;22(4):1826-7.
No abstract available

MeSH terms

  • Analysis of Variance
  • Antibodies, Monoclonal / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Candidiasis / etiology*
  • Critical Care
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Length of Stay
  • Liver Transplantation / adverse effects*
  • Muromonab-CD3
  • Regression Analysis
  • Risk Factors

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Muromonab-CD3